Brinzolamide serves as a specific carbonic anhydrase inhibitor targeting ocular hypertensive states for glaucoma. Inhibition of enzymes responsible for fluid secretion decreases internal pressure within the eye socket.
Brinzolamide belongs to the carbonic anhydrase inhibitor class of eye medicines. It works primarily to lower intra-ocular pressure, a key factor in several eye disorders. This active compound is found in the ophthalmic product Azopt, which is formulated as an eye-drop solution. Understanding what Brinzolamide does helps patients see why it is included in many Brinzolamide medications.
Azopt is marketed in Singapore as a sterile eye-drop containing 1 % brinzolamide. The same concentration appears in generic versions that carry the ingredient name on the label but may use a different brand name. Both brand and generic options are supplied in dropper bottles designed for easy administration to the eye surface. No other dosage forms, such as tablets or injectables, are typical for this ocular agent.
The drug is commonly employed for open-angle glaucoma, a condition where fluid buildup raises eye pressure. It also assists patients with ocular hypertension, where pressure is elevated without clear optic nerve damage. Secondary glaucoma types, including steroid-induced cases, may benefit from the pressure-lowering effect. Adults and older individuals who need long-term control of eye pressure often use formulations containing this active ingredient.
Brinzolamide reduces the production of aqueous humor, the fluid that nourishes the front part of the eye. By inhibiting a specific enzyme, it slows fluid formation, leading to a gradual decline in intra-ocular pressure. This mechanism helps maintain a safer pressure range without directly affecting drainage pathways.
Azopt eye drops should be stored at room temperature, away from direct sunlight and moisture. The bottle should be kept tightly closed when not in use to prevent contamination. Treatment with brinzolamide-containing eye drops is usually chronic, meaning patients may need to apply them daily for many months or years. Differences in dosage strength and instructions can exist between Azopt and its generic counterparts, so checking the label of the specific product is essential. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This text provides an educational overview of brinzolamide as an active substance and does not constitute medical advice. Individual medicines that contain this ingredient, such as Azopt, may vary in formulation, strength, and usage directions. The information presented carries no liability for clinical application. Readers are encouraged to review the labeling of their specific eye-drop product and seek guidance from a qualified healthcare professional for personal health decisions.
